HIV Research Today is a free monthly online journal that collates and summarizes the latest research about HIV, including details on human immunodeficiency virus, testing, treatment, prevention, vaccines, aids.

Volume 4 (2007), Issue 10 (October)

1. Herpes zoster infection as an immune reconstitution inflammatory syndrome in HIV-seropositive subjects: a review.
   Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 104(4): 455-60. [Abstract] [Full-text]
2. Fetal cord blood mononuclear cells that are collected at term from HIV-1 infected women harbor transcriptionally active integrated proviral DNA.
   Am J Obstet Gynecol, 197(4): 371.e1-6. [Abstract] [Full-text]
3. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover.
   J Exp Med, 204(10): 2473-85. [Abstract] [Full-text]
4. Efficacy of highly active antiretroviral therapy in HIV-1 infected children in Kenya.
   Pediatrics, 120(4): e856-61. [Abstract] [Full-text]
5. Colposcopy is not necessary to assess the risk to the cervix in HIV-positive women: an international cohort study of cervical pathology in HIV-1 positive women.
   Int J Cancer, 121(11): 2484-91. [Abstract] [Full-text]
6. Human immunodeficiency virus evolution towards reduced replicative fitness in vivo and the development of AIDS.
   Proc Biol Sci, 274(1624): 2481-90. [Abstract] [Full-text]
7. Successful efavirenz dose reduction in HIV type 1-infected individuals with cytochrome P450 2B6 *6 and *26.
   Clin Infect Dis, 45(9): 1230-7. [Abstract] [Full-text]
8. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
   Clin Infect Dis, 45(9): 1221-9. [Abstract] [Full-text]
9. Coinfection with HIV and tropical infectious diseases. II. Helminthic, fungal, bacterial, and viral pathogens.
   Clin Infect Dis, 45(9): 1214-20. [Abstract] [Full-text]
10. Coinfection with HIV and tropical infectious diseases. I. Protozoal pathogens.
    Clin Infect Dis, 45(9): 1208-13. [Abstract] [Full-text]
11. Human T lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in an HIV-positive patient coinfected with human T lymphotropic virus type 2 following initiation of antiretroviral therapy.
    Clin Infect Dis, 45(9): e118-20. [Abstract] [Full-text]
12. HIV-associated Kaposi sarcoma: pathogenic mechanisms.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 104(4): 521-9. [Abstract] [Full-text]
13. A synergistic effect of a combined bivalent DNA-protein anti-HIV-1 vaccine containing multiple T- and B-cell epitopes of HIV-1 proteins.
    Mol Immunol, 45(3): 661-9. [Abstract] [Full-text]
14. Mucosal safety of PHI-443 and stampidine as a combination microbicide to prevent genital transmission of HIV-1.
    Fertil Steril, 88(4): 1197-206. [Abstract] [Full-text]
15. Selective pressures of HLA genotypes and antiviral therapy on human immunodeficiency virus type 1 sequence mutation at a population level.
    Clin Vaccine Immunol, 14(10): 1266-73. [Abstract] [Full-text]
16. Seroincidence of recent human immunodeficiency virus type 1 infections in China.
    Clin Vaccine Immunol, 14(10): 1384-6. [Abstract] [Full-text]
17. Human immunodeficiency virus-1/surface glycoprotein 120 induces apoptosis through RNA-activated protein kinase signaling in neurons.
    J Neurosci, 27(41): 11047-55. [Abstract] [Full-text]
18. Dynein light chain 1 peptide inhibits human immunodeficiency virus infection in eukaryotic cells.
    Biochem Biophys Res Commun, 363(4): 901-7. [Abstract] [Full-text]
19. A 41-year-old HIV-positive man with acute onset of quadriplegia after West Nile virus infection.
    South Med J, 100(10): 1051-3. [Abstract] [Full-text]
20. Differences in the pre- and post-Katrina New Orleans HIV outpatient clinic population: who has returned?
    South Med J, 100(10): 999-1002. [Abstract] [Full-text]
21. Information systems for patient follow-up and chronic management of HIV and tuberculosis: a life-saving technology in resource-poor areas.
    J Med Internet Res, 9(4): e29. [Abstract] [Full-text]
22. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia.
    JAMA, 298(16): 1888-99. [Abstract] [Full-text]
23. Use of geographic information systems for planning HIV prevention interventions for high-risk youths.
    Am J Public Health, 97(11): 1974-81. [Abstract] [Full-text]
24. Gradations of researchers' obligation to provide ancillary care for HIV/AIDS in developing countries.
    Am J Public Health, 97(11): 1956-61. [Abstract] [Full-text]
25. Compassionate conservatism: federal funding for the Ryan White CARE Act during the Bush administration.
    Am J Public Health, 97(11): 2013-6. [Abstract] [Full-text]
26. A molecular dynamics study comparing a wild-type with a multiple drug resistant HIV protease: differences in flap and aspartate 25 cavity dimensions.
    Proteins, 69(3): 551-65. [Abstract] [Full-text]
27. High-mannose-specific deglycosylation of HIV-1 gp120 induced by resistance to cyanovirin-N and the impact on antibody neutralization.
    Virology, 368(1): 145-54. [Abstract] [Full-text]
28. The RING finger ubiquitin ligase RNF125/TRAC-1 down-modulates HIV-1 replication in primary human peripheral blood mononuclear cells.
    Virology, 368(1): 191-204. [Abstract] [Full-text]
29. Antiviral activity of a Rac GEF inhibitor characterized with a sensitive HIV/SIV fusion assay.
    Virology, 368(1): 1-6. [Abstract] [Full-text]
30. Structural constraints on human immunodeficiency virus type 1 Nef function.
    Virology, 368(1): 7-16. [Abstract] [Full-text]
31. Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies.
    Virology, 368(1): 172-81. [Abstract] [Full-text]
32. HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration.
    Virology, 368(1): 60-72. [Abstract] [Full-text]
33. Pentoxifylline suppresses transduction by HIV-1-based vectors.
    Intervirology, 50(5): 377-86. [Abstract] [Full-text]
34. Allosteric loss-of-function mutations in HIV-1 Nef from a long-term non-progressor.
    J Mol Biol, 374(1): 121-9. [Abstract] [Full-text]
35. An allosteric rheostat in HIV-1 gp120 reduces CCR5 stoichiometry required for membrane fusion and overcomes diverse entry limitations.
    J Mol Biol, 374(1): 64-79. [Abstract] [Full-text]
36. HIV infection increases the risk of heparin-induced thrombocytopenia.
    Clin Infect Dis, 45(10): 1393-6. [Abstract] [Full-text]
37. Managing symptomatic drug-induced liver injury in HIV-hepatitis C virus-coinfected patients: a role for interferon.
    Clin Infect Dis, 45(10): 1386-92. [Abstract] [Full-text]
38. Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women.
    Clin Infect Dis, 45(10): 1377-85. [Abstract] [Full-text]
39. Immune status at presentation to care did not improve among antiretroviral-naive persons from 1990 to 2006.
    Clin Infect Dis, 45(10): 1369-74. [Abstract] [Full-text]
40. Psychosis in a 12-year-old HIV-positive girl with an increased serum concentration of efavirenz.
    Clin Infect Dis, 45(10): e128-30. [Abstract] [Full-text]
41. HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and activates HIV transcription.
    PLoS Pathog, 3(10): 1459-69. [Abstract] [Full-text]
42. Advances in methods for the production, purification, and characterization of HIV-1 Gag-Env pseudovirion vaccines.
    Vaccine, 25(47): 8036-48. [Abstract] [Full-text]
43. An anti-apoptotic protein, Hax-1, inhibits the HIV-1 rev function by altering its sub-cellular localization.
    J Cell Physiol, 214(1): 14-9. [Abstract] [Full-text]

© 2004-2008 HIV Research Today. All Rights Reserved.